Daily administration of Clostridium butyricum CGMCC0313.1 for 13 weeks decreased Firmicutes/Bacteroidetes ratios and increased SCFA-producing bacteria and SCFA receptors FFAR2 and FFAR3 in T2D mice. Here, FFAR2 is linked to type 2 diabetes mellitus.